Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Non-interventional Observational Study to Characterize Dupilumab in the Long-term Management of Eosinophilic Esophagitis, Safety and Patient Reported Outcomes (Quality of Life) in Clinical Routine

NCT06695897 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT06695897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06695897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Non-interventional Observational Study to Characterize Dupilumab in the Long-term Management of Eosinophilic Esophagitis, Safety and Patient Reported Outcomes (Quality of Life) in Clinical Routine
Lead sponsor
Sanofi
Phase
Observational
Overall status
Recruiting
Start date
May 28, 2025
Completion date
May 29, 2029
Enrollment
150 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

eosinophilic esophagitis